Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production

BACKGROUND: Clinical translation of mesenchymal stromal cells (MSCs) necessitates basic characterization of the cell product since variability in biological source and processing of MSCs may impact therapeutic outcomes. Although expression of classical cell surface markers (e.g., CD90, CD73, CD105,...

Descripción completa

Detalles Bibliográficos
Autores principales: Camilleri, Emily T., Gustafson, Michael P., Dudakovic, Amel, Riester, Scott M., Garces, Catalina Galeano, Paradise, Christopher R., Takai, Hideki, Karperien, Marcel, Cool, Simon, Sampen, Hee-Jeong Im, Larson, A. Noelle, Qu, Wenchun, Smith, Jay, Dietz, Allan B., van Wijnen, Andre J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982273/
https://www.ncbi.nlm.nih.gov/pubmed/27515308
http://dx.doi.org/10.1186/s13287-016-0370-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982273/
https://www.ncbi.nlm.nih.gov/pubmed/27515308
http://dx.doi.org/10.1186/s13287-016-0370-8

Ejemplares similares